The U.S. Department of Health and Human Services, through the Office of the National Coordinator for Health Information Technology, has selected two projects to receive a combined $1.5 million under the 2026 Leading Edge Acceleration Projects in Health Information Technology program. The initiatives focus on the use of autonomous artificial intelligence in healthcare and on improving the ability of independent laboratories to exchange data with other health systems.
The announcement, released on October 6, 2026, places the projects within a broader effort to move artificial intelligence from experimental applications toward technologies that can be integrated into clinical workflows. Rather than funding a single commercial product, the program is supporting infrastructure, governance and interoperability projects that address how healthcare data is used, shared and monitored in the United States.
According to the Office of the National Coordinator for Health Information Technology, the two awardees are the MedStar Health Research Institute and the Regenstrief Institute. Their proposals address different parts of the digital healthcare ecosystem: one is centered on coordinating long-term clinical care, while the other targets gaps in laboratory interoperability.
MedStar project focuses on autonomous clinical coordination
The MedStar Health Research Institute project will develop an open-source infrastructure for organizing long-term medical follow-up with the support of autonomous artificial intelligence systems. In this context, agentic AI refers to systems designed to coordinate multiple steps in a process instead of merely generating an isolated response to a user request.
The proposal includes mechanisms intended to give patients greater control over their data. It also calls for verifiable model routing, allowing the system to identify how tasks are directed among different artificial intelligence models. This type of structure is relevant in clinical settings because decisions may depend on several data sources, specialized models and stages of patient care.
Another element described in the project is the use of cryptographic certificates. These certificates are intended to help identify changes or manipulation in automated decisions, creating a traceable record of how the system operates. The approach does not remove the need for clinical oversight, but it seeks to make automated processes more transparent and auditable.
For healthcare organizations, the proposal addresses a central challenge in the adoption of autonomous AI: how to allow software to coordinate activities while preserving patient consent, data control and accountability. The project’s open-source model could also support the development of tools that are easier to examine and adapt, although the announcement does not specify how or when the infrastructure will be deployed in routine care.
Regenstrief initiative targets laboratory data gaps
The second selected project will be led by the Regenstrief Institute and will focus on small independent laboratories. Its objective is to help these institutions adopt standardized terminology so that laboratory information can be interpreted more consistently by different digital health systems.
The initiative is expected to assess the technical readiness of participating laboratories, identify interoperability weaknesses, apply corrective strategies and measure improvements in the quality of data shared with other healthcare platforms. Standardized terminology is important because the same type of test or result can be represented differently across systems, creating barriers to communication and data reuse.
These differences can affect how information moves between laboratories, hospitals, physicians and other organizations involved in a patient’s care. By concentrating on smaller independent laboratories, the project also addresses institutions that may have fewer technical resources available for implementing complex data standards and maintaining connections with external systems.
The laboratory initiative complements the MedStar project. While one proposal explores how autonomous systems can coordinate clinical processes, the other works on the quality and consistency of the information those systems and healthcare professionals may need to use.
Why interoperability matters for healthcare AI
Artificial intelligence in healthcare depends not only on the performance of its models but also on the availability of reliable, well-structured information. If laboratory results cannot be correctly understood across platforms, an automated system may face incomplete or inconsistent data. Interoperability therefore becomes a foundation for deploying AI in clinical environments.
The federal funding also highlights that safety concerns extend beyond the algorithms themselves. Patient consent, control over personal information, traceability of automated decisions and the ability to detect unauthorized changes are all part of the infrastructure needed for responsible adoption. These issues become especially important when systems are designed to coordinate several steps in a patient’s care.
The ONC Media Center records the October 6 announcement as part of the agency’s 2026 communications. The selection of two projects under LEAP in Health IT signals continued federal interest in practical solutions for clinical technology, particularly those that connect artificial intelligence with data standards and governance.
The projects will not, by themselves, resolve every challenge associated with autonomous AI or fragmented laboratory systems. However, they illustrate two conditions that may determine whether these technologies can be adopted at scale in the United States: healthcare organizations need systems that can exchange information reliably, and patients and clinicians need clear mechanisms to understand and oversee automated activity.
